×
  • Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 

Pharma point multiple sclerosis india drug forecast and market analysis to 2022 - Reports Corner

by Working at Reports Corner on May 02, 2013

  • 336 views

Global Data has released its new Country report, "PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022". Multiple sclerosis (MS) is a chronic, inflammatory neurological ...

Global Data has released its new Country report, "PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022". Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system.

https://www.reportscorner.com/reports/15505/PharmaPoint:-Multiple-Sclerosis---India-Drug-Forecast-and-Market-Analysis-to-2022/

Statistics

Views

Total Views
336
Views on SlideShare
336
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via SlideShare as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
Post Comment
Edit your comment

Pharma point multiple sclerosis   india drug forecast and market analysis to 2022 - Reports Corner Pharma point multiple sclerosis india drug forecast and market analysis to 2022 - Reports Corner Presentation Transcript